Nina A Tomei, MD

1.4K posts

Nina A Tomei, MD banner
Nina A Tomei, MD

Nina A Tomei, MD

@doctormom63

Life interrrupted by debilitating chronic illness. Surviving Not Living. Sick Not Tired. #MECFS We just want our lives back. Posts are not medical advice.

USA Katılım Ağustos 2015
1.1K Takip Edilen3.8K Takipçiler
Nina A Tomei, MD
Nina A Tomei, MD@doctormom63·
@DafoeWhitney This is beautiful, Whitney. I’m printing this out tomorrow to put on my wall. 🫂
English
1
0
7
239
Nina A Tomei, MD retweetledi
Whitney Dafoe
Whitney Dafoe@DafoeWhitney·
Living just one more day with #MECFS is the saddest, most horrifying thing I could imagine.  But I’m going to do it.  I’m going to wake up tomorrow and let another day slide past me without living it.  And I’m going to get up the next day and do it again.  Acceptance, letting go, courage, crying, cursing, righteous anger, pulling out what’s left of my hair, whatever it takes to get through one more day and closer to that day when we get real treatments and a cure.  It breaks my heart every single day, but I can live with a broken heart.  I need to feel freedom again. #pwME #ChronicIllness
English
40
90
662
10.7K
Nina A Tomei, MD retweetledi
Ralf Wittenbrink
Ralf Wittenbrink@RWittenbrink·
Neuroinflammation der weißen Substanz bei ME/CFS Diese neue Studie liefert mithilfe moderner Diffusionsbildgebung (Neuroinflammation Imaging, NII) die bislang wohl klarsten bildgebenden Belege dafür, dass ME/CFS mit entzündlichen Veränderungen der weißen Hirnsubstanz einhergeht.
Ralf Wittenbrink tweet media
Florian Riegler@derrieglerflo

Neuroinflammation bei ME/CFS erstmals im Gehirn 🧠 sichtbar gemacht! Studie: onlinelibrary.wiley.com/doi/full/10.10…

Deutsch
1
119
302
9.6K
Nina A Tomei, MD
Nina A Tomei, MD@doctormom63·
@trishorwen Thank you for your kind words! I know she’ll be so touched to hear this
English
0
0
1
50
Trish Orwen
Trish Orwen@trishorwen·
@doctormom63 She is such a talented writer — I pray she gets a treatment one day so that she can live the life she writes about.
English
1
0
2
71
Nina A Tomei, MD
Nina A Tomei, MD@doctormom63·
@NeleHelena Thank you so much, I will pass along to her what you said. She hasn’t been active here lately but may try to come back.
English
0
0
3
70
Nele
Nele@NeleHelena·
@doctormom63 Your daughter writes so beautifully ❤️‍🩹 Is she still on twitter?
English
1
0
3
157
Nina A Tomei, MD
Nina A Tomei, MD@doctormom63·
Grateful for the 2 year extension of Telehealth coverage for Medicare. It is essential for the disabled, chronically ill, house-bound and bedridden patients for whom getting to the doctor's office may not only be extremely difficult, but may also result in worsening of their condition. When you become disabled, you must purchase Medicare as your health insurance, even though you are under 65. Telehealth coverage for those of us on Medicare who are too ill to even leave our homes should be made permanent. Let our doctors decide when we need to be seen in person. #MECFS #LongCovid #Sjogrens #POTS #chronicillness #disability #telehealth @WhiteHouse @POTUS @realDonaldTrump @RobertKennedyJr @DrOz @VP @LeaderJohnThune @MikeJohnson @SenBrianSchatz
English
0
1
7
680
Nina A Tomei, MD retweetledi
ME/CFS Science
ME/CFS Science@mecfsskeptic·
1) Dr. Felipe Correa da Silva shared more info about the first 10 brain autopsies from the Netherlands. In this new thread, we made a brief summary of his presentation.
ME/CFS Science tweet media
ME/CFS Science@mecfsskeptic

1) This year, there were reports of 7 autopsies of ME/CFS patients, showing a dramatic reduction in CRH-producing neurons. This info was shared at the IACFS/ME conference, but the results still haven’t been published yet. Similar findings have been found in type 1 narcolepsy.

English
12
98
277
27.2K
Nina A Tomei, MD
Nina A Tomei, MD@doctormom63·
@WhiteHouse @POTUS @SenBrianSchatz @RobertKennedyJr @DrOz @SenRickScott @SenAshleyMoody @MarioDB We are grateful for the 2 year extension of Telehealth coverage for Medicare--it is essential for the disabled, chronically ill, house-bound and bedridden patients for whom getting to the doctor's office may not only be extremely difficult, but may also result in worsening of their condition. Many do not realize that when you become disabled, you must purchase Medicare as your health insurance. Telehealth coverage for those of us on Medicare who are too ill to even leave our homes should be made permanent. Let our doctors decide when we need to be seen in person. #MECFS #LongCovid #Sjogrens #POTS #chronicillness #disability #telehealth
English
0
0
6
79
Nina A Tomei, MD retweetledi
Maureen Hanson
Maureen Hanson@DrMaureenHanson·
In pre-2020 ME cases, analysis of over 7000 proteins demonstrates that exertion disrupts T and B cell signaling, IL-17 pathways, and mitochondrial metabolism in comparison to healthy sedentary controls. Protein signatures correlate with symptom severity.
Maureen Hanson tweet media
English
9
114
384
11.7K
Nina A Tomei, MD retweetledi
Jack | amatica health
Jack | amatica health@JackHadfield14·
New research has identified a potential biological cause for post-COVID fatigue/muscle fatigue. Scientists found that a molecule called soluble IL-2 receptor (sIL-2R), linked to immune activation, may directly harm mitochondria in muscle cells.
Jack | amatica health tweet media
English
20
130
488
15.8K
Nina A Tomei, MD retweetledi
Jack | amatica health
Jack | amatica health@JackHadfield14·
The recent RAPAMYCIN study - while solid research - overstates its findings. What it actually shows is that RAPA works for a subgroup. Response rate was 33.7% (16.3% being minor gains), not 72.5% once dropouts are counted. But it shows proof of concept. Let’s break it down 🧵
English
12
13
145
4.7K
Nina A Tomei, MD retweetledi
Hannah Davis
Hannah Davis@ahandvanish·
Cool mouse study shows inhibiting 15-PGDH prevents deterioration of the blood-brain barrier and protects mice in Alzheimer's and traumatic brain injury: pnas.org/doi/10.1073/pn… #LongCovid
English
0
5
21
1.4K
Nina A Tomei, MD retweetledi
Patient-Led Research Collaborative
"There is a fundamental inability in some people to clear the virus in the acute phase" — @VirusesImmunity at the @HHSGov roundtable on #LongCovid last week. She outlines the fundamental drivers of LC, and recommends strategies to address the root cause of symptoms👇
English
15
82
280
17.5K
Nina A Tomei, MD retweetledi
Brain Inflammation Collaborative
Brain Inflammation Collaborative@BrainInflCollab·
It's estimated that 65 million individuals worldwide are affected by ME/CFS (1). However, there are no clinically validated biomarkers. Here's why that could change...🧵
Brain Inflammation Collaborative tweet media
English
4
54
259
9.5K
Nina A Tomei, MD retweetledi
Putrino Lab
Putrino Lab@PutrinoLab·
Ok, so after that (unintentional) cliffhanger, let's talk about energy production infrastructure and post-exertional malaise (PEM) in people with infection- and exposure-associated chronic illnesses (IACIs) such as #LongCOVID, #MECFS, chronic #Lyme and more. Let's start with 1/
English
29
212
697
53K
Nina A Tomei, MD retweetledi
Dysautonomia Intl.
Dysautonomia Intl.@Dysautonomia·
Good news for dysautonomia patients w/ Sjogren's! Ianalumab is the 1st immunotherapy to have successful Phase 3 trials in Sjogren's, which means it has a real chance to obtain FDA approval. Sjogren's is the 2nd most common cause of autonomic neuropathy. novartis.com/news/media-rel…
English
6
49
142
8.9K
Nina A Tomei, MD retweetledi
Amy Proal, PhD
Amy Proal, PhD@microbeminded2·
So glad to join this SPEAR Study Group! LongCOVID & Post Vaccine Syndrome patients have waited way too long for expanded research on how #monoclonal antibodies - including those with broadly neutralizing activity - may improve their symptoms. We intend to change that!
Invivyd@Invivyd

BREAKING: Anecdotes are wonderful - let’s go get the data! Invivyd & leading researchers launch SPEAR Study Group to explore effects of mAb therapy on people suffering from Long COVID & post-vaccination syndrome. investors.adagiotx.com/news-releases/… @UCSF @polybioRF @michaelpelusoMD @microbeminded2 @putrinolab #LongCOVID #LongCovid

English
28
90
377
32.9K